Veto cells may shield transplant patients from dangerous immune attack
NCT ID NCT03622788
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 23 times
Summary
This study tests whether special immune cells called veto cells can help donor stem cells grow in patients with blood cancers after a transplant, without causing severe graft-versus-host disease (GVHD). About 16 patients aged 12-75 will receive these cells alongside standard chemotherapy and radiation. The goal is to find a safe dose that improves survival and reduces complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.